Articles by Rob Woolfenden II - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Rob Woolfenden II

Rob Woolfenden II


Rob Woolfenden II is principal engineer in the process development department at Amgen, Inc.

Monitoring of Biopharmaceutical Processes: Present and Future Approaches
May 1, 2009

This article reviews some of the commonly used approaches for process monitoring as well as the evolution of process monitoring in the Quality by Design (QbD) paradigm.

ADVERTISEMENT

ADVERTISEMENT

Click here